[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Is your medical equipment vulnerable to a cyberattack? You better find out.

by Jackie (née Heneghan) Peck | Jul 24, 2017 | Blog

Is the software embedded in your medical equipment vulnerable to a cyberattack? Equipment running older software is much more vulnerable to cyberattack. Older software may be embedded in medical devices and may require regular updates. Find out if it is possible?...

Seven useful terms explained for new wholesalers who want to Export medicines out of the EEA.

by Jackie (née Heneghan) Peck | Jun 21, 2017 | Blog, Export Training, Training

Seven useful terms: “IATA” “The International Air Transport Association “this body regulates air travel worldwide. IATA are responsible for security and safety of air travel and the regulation of air transport of dangerous goods. “CEIV “Centre of Excellence for...

Contracting a Consultant is only half the battle!

by Jackie (née Heneghan) Peck | Jun 21, 2017 | Blog, Consultancy

Quality Management Systems (QMS) for Wholesalers can be built by a consultant alone, but the best QMS is one which has input from the Company, the staff who carry out the activities and the managers who are responsible for the business and specific processes within...

The UK may see medicine shortages and delays in the introduction of new medicines after Brexit.

by Jackie (née Heneghan) Peck | Jun 12, 2017 | Brexit, NHS

The EU market accounts for 25% of all global medicines sales, when we break away and become a smaller separate market, companies may very well priorities bigger markets to introduce their medicines into over the UK.  The NHS may as a result struggle to access...

Centrally authorised Medicinal Products for Human and Veterinary Use

by Jackie (née Heneghan) Peck | May 23, 2017 | Blog, Brexit, Good Distribution Practice - GDP, WDA(H)

The UK triggered Article 50 of the Treaty on European Union on 29th of March 2017 and as a result all primary and secondary law ceases to apply to the UK from 30th of March 2019. Companies who hold centrally authorised “MA s” must proactively review their MA terms,...
« Older Entries
Next Entries »

Recent Posts

  • Minister responsible for Pharmacy announced
  • Heatwaves, Medicines and the Leadership Imperative
  • Climate Change Is Creating a New Challenge for Medicines Storage

Upcoming Courses

  • Introduction to Good Distribution Practice Online Training on 4 November 2026 10:00 am
  • Licence Holder Training on 5 November 2026 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 17 November 2026
  • Superintendent Pharmacist training (Online) on 25 November 2026
  • RP Forum – tbc on 1 December 2026 10:00 am

MHRA Alerts & Recalls

MHRA Safety Roundup: October 2026
30 October 2026
Class 2 Medicines Recall: Accord-UK Ltd, Lercanidipine Hydrochloride 10mg Film-Coated Tablets, EL(26)A/45
29 October 2026
Class 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44
29 October 2026
Field Safety Notices: 19 to 23 October 2026
28 October 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow